Compare · CLOV vs ELV
CLOV vs ELV
Side-by-side comparison of Clover Health Investments Corp. (CLOV) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLOV and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.91B, about 37.4x CLOV ($2.49B).
- Over the past year, CLOV is up 66.4% and ELV is up 23.1% - CLOV leads by 43.3 points.
- CLOV has been more active in the news (15 items in the past 4 weeks vs 3 for ELV).
- ELV has more recent analyst coverage (23 ratings vs 13 for CLOV).
- Company
- Clover Health Investments Corp.
- Elevance Health Inc.
- Price
- $4.49-4.27%
- $428.56+0.04%
- Market cap
- $2.49B
- $92.91B
- 1M return
- -0.99%
- +3.42%
- 1Y return
- +66.42%
- +23.10%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 15
- 3
- Recent ratings
- 13
- 23
Clover Health Investments Corp.
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest CLOV
- SEC Form 8-K filed by Clover Health Investments Corp.
- Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
- SEC Form 4 filed by Clover Health Investments Corp.
- Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
- SEC Form 4 filed by Clover Health Investments Corp.
- Director Miller Brian James was granted 12,481 shares (SEC Form 4)
- Director Torricelli Robert G was granted 12,481 shares, increasing direct ownership by 7% to 186,897 units (SEC Form 4)
- Chief Executive Officer Toy Andrew sold $1,335,797 worth of shares (318,806 units at $4.19), decreasing direct ownership by 3% to 9,140,510 units (SEC Form 4) to cover taxes
- New insider Torricelli Robert G claimed ownership of 174,416 shares (SEC Form 3)
- SEC Form 3 filed by new insider Miller Brian James
Latest ELV
- SEC Form 4 filed by Elevance Health Inc.
- Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 349 shares, decreasing direct ownership by 5% to 7,230 units (SEC Form 4)
- EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 144 shares, decreasing direct ownership by 2% to 6,530 units (SEC Form 4)
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.